William R Short, MD, MPH, FIDSA
Associate Professor of Clinical Medicine (Infectious Diseases)
Attending Physician, Penn Presbyterian Medical Center
Attending Physician, Helen O. Dickens Center for Women, Hospital of the University of Pennsylvania
Attending Physician, Hospital of the University of Pennsylvania
Associate Director & Co-Investigator, AIDS Clinical Trial Unit (ACTU) research site , University of Pennsylvania
Clinical Associate, School of Nursing
Co-Director, Penn Center For AIDS Research, clinical core, University of Pennsylvania
Inter-CFAR Working Group on HIV in Women Executive Meeting, University of Pennsylvania
Department: Medicine
Contact information
Medical Arts Building
3801 Filbert St, suite 103
Philadelphia, PA 19104
3801 Filbert St, suite 103
Philadelphia, PA 19104
Office: 215-662-8693
Fax: 215-243-4658
Fax: 215-243-4658
Education:
AS (Nursing)
Hahnemann University, School of Allied Health Professions, 1986.
BS
Hahnemann University School of Health Sciences and Professions, 1989.
MD
Hahnemann University School of Medicine, 1997.
MPH (Epidemiology and Health Systems Policy)
UMDNJ School of Public Health, 2009.
MSCE (Clinical Epidemiology )
University of Pennsylvania, 2023.
Permanent linkAS (Nursing)
Hahnemann University, School of Allied Health Professions, 1986.
BS
Hahnemann University School of Health Sciences and Professions, 1989.
MD
Hahnemann University School of Medicine, 1997.
MPH (Epidemiology and Health Systems Policy)
UMDNJ School of Public Health, 2009.
MSCE (Clinical Epidemiology )
University of Pennsylvania, 2023.
Description of Clinical Expertise
management of HIV infection; management of pregnant women living with HIV; sexually transmitted infections.Selected Publications
Anderson D, Ramgopal M, Hagins DP, Lee J, Simonson RB, Hsu TH, Xu P, Ahmad N, Short WR. : DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-based Regimen Switch Strategy to Manage Integrase Inhibitor-related Weight Gain. Clinical Infectious Diseases September 2024.Cluck DB, Chastain DB, Murray M, Durham SH, Chahine EB, Derrick C, Dumond JB, Hester EK, Jeter SB, Johnson MD, Kilcrease C, Kufel WD, Kwong J, Ladak AF, Patel N, Pérez SE, Poe JB, Bolch C, Thomas I, Asiago-Reddy E, Short WR.: Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy. Pharmacotherapy 44(5): 360-382, May 2024.
Gandhi M, Hill L, Grochowski J, Nelson A, Koss CA, Mayorga-Munoz F, Oskarsson J, Shiels M, Avery A, Bamford L, Baron J, Short WR, Hileman CO: Case Series of People with HIV on the Long-Acting Combination of Lenacapravir and Cabotegravir: Call for a Trial. Open Forum Infectious Diseases 11(4): ofae 125, April 2024 Notes: published on line.
Holt LM, Short WR, Momplaisir F, Hyun E, McKinney J, Morales AL, Duque A, Druyan B, Ndubizu C, Duthely L, Joseph N, Sheth A, Badell ML.: Bictegravir use during pregnancy: a multi-center retrospective analysis evaluating HIV viral suppression and perinatal outcomes. Clinical Infectious Diseases April 2024 Notes: published online ahead of print.
Paules CI, Wang J, Tomashek KM, Bonnett T, Singh K, Marconi VC, Davey RT, Lye DC, Dodd LE, Yang OO, Benson CA, Deye GA, Doernberg SB, Hynes NA, Grossberg R, Wolfe CR, Nayak SU, Short WR, Voell J, Potter GE, Rapaka RR.: A Risk Profile Driven by Simple Hematologic Parameters Predicts Differential Benefit from Baricitinib in Hospitalized COVID-19 Patients: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2. Annals of Internal Medicine 177(3): 343-352, March 2024 Notes: Epub ahead of print.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group.: Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials. EClinicalMedicine 9(69): 102472, February 2024.
Omoz-Oarhe AE, Hughes MD, Yajing B, Short WR, Mngqibisa R, Cohn SE, Weinberg A, La Rosa A, Collier A, Samaneka W, Morroni C, Lockman : Incidence and Predictors of Pregnancy in Women Enrolled in Large Multi-National HIV Treatment Trials of the AIDS Clinical Trials Group. JAIDS 94(5): 461-467, December 2023.
Sonalkar S, Kete C, McAllister A, Afren R, Kaufman J, Short W, Keddem S.: Perceptions of HIV risk screening strategies among patients seeking abortion, contraception, and pregnancy loss management in the United States. Contraception. Elsevier, 124(11): 110063, August 2023.
Tebas P, Lynn K, Azzoni L, Cocchella G, Papasavvas E, Fair M, Karanam B, Sharma P, Reeves JD, Petropoulos CJ, Lalley-Chareczko L, Kostman JR, Short W, Mounzer K, Montaner LJ. : Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons. AIDS 37(8): 1203-1207, July 2023 Notes: Epub April 2023.
Ortega-Villa AM, Hynes NA, Levine CB, Yang K, Wiley Z, Jilg N, Wang J, Whitaker JA, Colombo CJ, Nayak SU, Kim HJ, Iovine NM, Ince D, Cohen SH, Langer AJ, Wortham JM, Atmar RL, El Sahly HM, Jain M, Mehta AK, Wolfe CR, Gomez CA, Beresnev T, Mularski RA, Paules CI, Kalil AC, Branche AR, Luetkemeyer A, Zingman BS, Voell J, Whitaker M, Harkins MS, Davey RT, Grossberg R, George SL, Tapson V, Short WR, Ghazaryan V, Benson CA, Dodd LE, Sweeney DA, Tomashek KM.: Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive COVID-19 Treatment Trial (ACTT) as a Test Case. Open Forum Infectious Diseases 27(10): 1-9, May 2023.